ROVIPHARM

Since 2018, Rovipharm has become part of the SGH Medical Pharma Group. SGH is an international french group which has become a global market leader in the design, development and manufacturing of Medical and Pharmaceutical devices. Stiplastics, Eskiss, and Rovipharm have been united under the SGH Medical Pharma group due to their collective expertise and wealth of knowledge Our core are channeled into three distinct business segments : the production of Drug Delivery Devices, the manufacturing of Primary Packaging for Nutraceuticals, and our dedicated Specific Development department. The Rovipharm subsidiary is specialised in dosing devices, including oral dosing syringes and...

Plastic injection,dosing syringes,droppers,dosing cups,dosing spoons,medical devices,ce marking,innovations ,project management ,quality control,and good manufacturing practice

Rovipharm operates in the Pharmaceutical manufacturing industry.

Rovipharm's revenue is 11m - 100m

Rovipharm has 11 - 50 employees.